These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38597655)

  • 21. Borrelia burgdorferi VlsE antigen for the serological diagnosis of Lyme borreliosis.
    Marangoni A; Moroni A; Accardo S; Cevenini R
    Eur J Clin Microbiol Infect Dis; 2008 May; 27(5):349-54. PubMed ID: 18197445
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiplex immunoassay for Lyme disease using VlsE1-IgG and pepC10-IgM antibodies: improving test performance through bioinformatics.
    Porwancher RB; Hagerty CG; Fan J; Landsberg L; Johnson BJ; Kopnitsky M; Steere AC; Kulas K; Wong SJ
    Clin Vaccine Immunol; 2011 May; 18(5):851-9. PubMed ID: 21367982
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of Modified 2-Tiered Serodiagnostic Testing Algorithms for Early Lyme Disease.
    Branda JA; Strle K; Nigrovic LE; Lantos PM; Lepore TJ; Damle NS; Ferraro MJ; Steere AC
    Clin Infect Dis; 2017 Apr; 64(8):1074-1080. PubMed ID: 28329259
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lyme Disease Diagnosis: Serology.
    Schriefer ME
    Clin Lab Med; 2015 Dec; 35(4):797-814. PubMed ID: 26593258
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of a sequential enzyme immunoassay testing algorithm for Lyme disease demonstrates lack of test independence but high diagnostic specificity.
    Wormser GP; Molins CR; Levin A; Lipsett SC; Nigrovic LE; Schriefer ME; Branda JA
    Diagn Microbiol Infect Dis; 2018 Jul; 91(3):217-219. PubMed ID: 29550060
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New laboratory guidelines for serologic diagnosis of Lyme disease: evaluation of the two-test protocol.
    Ledue TB; Collins MF; Craig WY
    J Clin Microbiol; 1996 Oct; 34(10):2343-50. PubMed ID: 8880477
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modified interpretation criteria significantly improve performance of commercially available confirmatory assays for the serodiagnosis of Lyme borreliosis: a case-control study with clinically defined serum samples.
    Hauser U
    Eur J Clin Microbiol Infect Dis; 2019 Mar; 38(3):529-539. PubMed ID: 30715667
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 2-tiered antibody testing for early and late Lyme disease using only an immunoglobulin G blot with the addition of a VlsE band as the second-tier test.
    Branda JA; Aguero-Rosenfeld ME; Ferraro MJ; Johnson BJ; Wormser GP; Steere AC
    Clin Infect Dis; 2010 Jan; 50(1):20-6. PubMed ID: 19947857
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development and laboratory evaluation of a new recombinant ELISA for the serodiagnosis of Lyme disease.
    Hunfeld KP; Ernst M; Zachary P; Jaulhac B; Sonneborn HH; Brade V
    Wien Klin Wochenschr; 2002 Jul; 114(13-14):580-5. PubMed ID: 12422605
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Two-tiered antibody testing for Lyme disease with use of 2 enzyme immunoassays, a whole-cell sonicate enzyme immunoassay followed by a VlsE C6 peptide enzyme immunoassay.
    Branda JA; Linskey K; Kim YA; Steere AC; Ferraro MJ
    Clin Infect Dis; 2011 Sep; 53(6):541-7. PubMed ID: 21865190
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enzyme-linked immunosorbent assay, immunofluorescent assay, and recombinant immunoblotting in the serodiagnosis of early Lyme borreliosis.
    Christova I
    Int J Immunopathol Pharmacol; 2003; 16(3):261-8. PubMed ID: 14611730
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of an automated Borrelia indirect chemiluminescent immunoassay (CLIA) with a VlsE/C6 ELISA and Immunoblot.
    Riesbeck K; Hammas B
    Eur J Clin Microbiol Infect Dis; 2007 Jul; 26(7):517-9. PubMed ID: 17558488
    [No Abstract]   [Full Text] [Related]  

  • 33. Correlation of tests for detection of Borrelia burgdorferi sensu lato infection in patients with diagnosed borreliosis.
    Chmielewska-Badora J; Cisak E; Wójcik-Fatla A; Zwoliński J; Buczek A; Dutkiewicz J
    Ann Agric Environ Med; 2006; 13(2):307-11. PubMed ID: 17196006
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Simple objective detection of human lyme disease infection using immuno-PCR and a single recombinant hybrid antigen.
    Halpern MD; Molins CR; Schriefer M; Jewett MW
    Clin Vaccine Immunol; 2014 Aug; 21(8):1094-105. PubMed ID: 24899074
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Utility of serodiagnostics designed for use in the United States for detection of Lyme borreliosis acquired in Europe and vice versa.
    Wormser GP; Tang AT; Schimmoeller NR; Bittker S; Cooper D; Visintainer P; Aguero-Rosenfeld ME; Ogrinc K; Strle F; Stanek G
    Med Microbiol Immunol; 2014 Feb; 203(1):65-71. PubMed ID: 24218117
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pediatric decision limits for serologic screening of Lyme disease.
    Lopez-Nunez O; Srivastava P; Wheeler BJ; Oakes N; Thomas H; Nowalk A; Wheeler S
    Clin Biochem; 2021 May; 91():59-62. PubMed ID: 33617846
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Persistent Anti-
    Markowicz M; Reiter M; Gamper J; Stanek G; Stockinger H
    Microbiol Spectr; 2021 Dec; 9(3):e0102021. PubMed ID: 34937165
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improvement of Lyme borreliosis serodiagnosis by a newly developed recombinant immunoglobulin G (IgG) and IgM line immunoblot assay and addition of VlsE and DbpA homologues.
    Goettner G; Schulte-Spechtel U; Hillermann R; Liegl G; Wilske B; Fingerle V
    J Clin Microbiol; 2005 Aug; 43(8):3602-9. PubMed ID: 16081885
    [TBL] [Abstract][Full Text] [Related]  

  • 39. C6 Peptide-Based Multiplex Phosphorescence Analysis (PHOSPHAN) for Serologic Confirmation of Lyme Borreliosis.
    Pomelova VG; Korenberg EI; Kuznetsova TI; Bychenkova TA; Bekman NI; Osin NS
    PLoS One; 2015; 10(7):e0130048. PubMed ID: 26147441
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The VlsE (IR6) peptide ELISA in the serodiagnosis of lyme facial paralysis.
    Peltomaa M; McHugh G; Steere AC
    Otol Neurotol; 2004 Sep; 25(5):838-41. PubMed ID: 15354020
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.